Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette Arnold

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Virology|June 12, 2009
Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidaseMostafa Jarahian, Carsten Watzl, Philippe Fournier, et al.
Frontiers in Cell and Developmental Biology|January 23, 2023
ADAR RNA editing on antisense RNAs results in apparent U-to-C base changes on overlapping sense transcriptsRiccardo Pecori, Isabel Chillón, Claudio Lo Giudice, et al.
Cancer Immunology Research|March 9, 2018
CD16A Activation of NK Cells Promotes NK Cell Proliferation and Memory-Like Cytotoxicity against Cancer CellsJens H W Pahl, Joachim Koch, Jana-Julia Götz, et al.
Molecular Therapy. Nucleic Acids|September 30, 2021
MultiEditR: The first tool for the detection and quantification of RNA editing from Sanger sequencing demonstrates comparable fidelity to RNA-seqMitchell G Kluesner, Rafail Nikolaos Tasakis, Taga Lerner, et al.
Cancer Research|May 1, 2014
Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30Eva Schlecker, Nathalie Fiegler, Annette Arnold, et al.
Oncoimmunology|September 14, 2016
The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cellsSonja Textor, Felicitas Bossler, Kai-Oliver Henrich, et al.
Immunity|May 24, 2020
Single-Cell RNA Sequencing of Tumor-Infiltrating NK Cells Reveals that Inhibition of Transcription Factor HIF-1α Unleashes NK Cell ActivityJing Ni, Xi Wang, Ana Stojanovic, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Employing RNA editing to engineer personalized tumor-specific neoantigens (editopes)Riccardo Pecori, Beatrice Casati, Rona Merdler-Rabinowicz, et al.
Iscience|May 31, 2023
ADAR1-mediated RNA editing promotes B cell lymphomagenesisRiccardo Pecori, Weicheng Ren, Mohammad Pirmoradian, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Virology|June 12, 2009
Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidaseMostafa Jarahian, Carsten Watzl, Philippe Fournier, et al.
Frontiers in Cell and Developmental Biology|January 23, 2023
ADAR RNA editing on antisense RNAs results in apparent U-to-C base changes on overlapping sense transcriptsRiccardo Pecori, Isabel Chillón, Claudio Lo Giudice, et al.
Cancer Immunology Research|March 9, 2018
CD16A Activation of NK Cells Promotes NK Cell Proliferation and Memory-Like Cytotoxicity against Cancer CellsJens H W Pahl, Joachim Koch, Jana-Julia Götz, et al.
Molecular Therapy. Nucleic Acids|September 30, 2021
MultiEditR: The first tool for the detection and quantification of RNA editing from Sanger sequencing demonstrates comparable fidelity to RNA-seqMitchell G Kluesner, Rafail Nikolaos Tasakis, Taga Lerner, et al.
Cancer Research|May 1, 2014
Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30Eva Schlecker, Nathalie Fiegler, Annette Arnold, et al.
Oncoimmunology|September 14, 2016
The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cellsSonja Textor, Felicitas Bossler, Kai-Oliver Henrich, et al.
Immunity|May 24, 2020
Single-Cell RNA Sequencing of Tumor-Infiltrating NK Cells Reveals that Inhibition of Transcription Factor HIF-1α Unleashes NK Cell ActivityJing Ni, Xi Wang, Ana Stojanovic, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Employing RNA editing to engineer personalized tumor-specific neoantigens (editopes)Riccardo Pecori, Beatrice Casati, Rona Merdler-Rabinowicz, et al.
Iscience|May 31, 2023
ADAR1-mediated RNA editing promotes B cell lymphomagenesisRiccardo Pecori, Weicheng Ren, Mohammad Pirmoradian, et al.
Pageof 2